Pauline Raaschou

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: HEALTH SCIENCE REPORTS. 2023;6(11):e1692
Anticoagulant treatment and COVID-19 mortality among older adults living in nursing homes in Sweden
Kananen L; Molnar C; Ansker F; Kozlowska DJ; Hagg S; Jylhava J; Religa D; Raaschou P
Article: BIOETHICS. 2023;37(7):668-673
Should relational effects be considered in health care priority setting?
Gustavsson E; Juth N; Larfars G; Raaschou P; Sandman L
Article: JOURNAL OF MEDICAL ETHICS. 2021;47(9):608-614
Novel drug candidates targeting Alzheimer's disease: ethical challenges with identifying the relevant patient population
Gustavsson E; Raaschou P; Larfars G; Sandman L; Juth N
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(7):1029-1041
Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy-a retrospective analysis of a register-based patient cohort
Ekheden I; Ebrahim F; olafsdottir H; Raaschou P; Wettermark B; Henriksson R; Ye W
Article: ACTA PAEDIATRICA. 2019;108(7):1250-1255
Snus users had high levels of nicotine, cotinine and 3-hydroxycotinine in their breastmilk, and the clearance was slower than in smoking mothers
Nordenstam F; Lundell B; Bonamy A-KE; Raaschou P; Wickstrom R
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2018;97(11):1373-1380
Maternal snuff use and cotinine in late pregnancy-A validation study
Gunnerbeck A; Raaschou P; Cnattingius S; Bonamy A-KE; Wickstrom R
Article: ANNALS OF INTERNAL MEDICINE. 2018;169(5):291-299
Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis A Nationwide Population-Based Cohort Study
Raaschou P; Soderling J; Turesson C; Askling J
Article: NICOTINE & TOBACCO RESEARCH. 2017;19(7):797-803
Prenatal Exposure to Snus Alters Heart Rate Variability in the Infant
Nordenstam F; Lundell B; Cohen G; Tessma MK; Raaschou P; Wickstrom R
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):386-391
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Mercer LK; Askling J; Raaschou P; Dixon WG; Dreyer L; Hetland ML; Strangfeld A; Zink A; Mariette X; Finckh A; Canhao H; Lannone F; Zavada J; Morel J; Gottenberg J-E; Hyrich KL; Listing J
Article: BMJ-BRITISH MEDICAL JOURNAL. 2016;352:i262
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden
Raaschou P; Simard JF; Hagelberg CA; Askling J
Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2137-2143
TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
Raaschou P; Frisell T; Askling J
Article: BMJ-BRITISH MEDICAL JOURNAL. 2013;346:f1939
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
Raaschou P; Simard JF; Holmqvist M; Askling J
Article: LAKARTIDNINGEN. 2013;110(3):82-84
[Observational cohort studies. Overview and some examples from the field of drug safety].
Holmqvist M; Raaschou P; Neovius M; Askling J
Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(7):1812-1822
Does Cancer That Occurs During or After Anti-Tumor Necrosis Factor Therapy Have a Worse Prognosis? A National Assessment of Overall and Site-Specific Cancer Survival in Rheumatoid Arthritis Patients Treated With Biologic Agents
Raaschou P; Simard JF; Neovius M; Askling J
Article: JOURNAL OF OBESITY. 2011;2011:459263-7
Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care
Forslund T; Raaschou P; Hjemdahl P; Krakau I; Wettermark B
Article: LAKARTIDNINGEN. 2010;107(13-14):910-913
[Anti-obesity agents do not seem to have any beneficial effects. Health centers prescribe preparations haphazardly, according to a medical records study].
Forslund T; Wettermark B; Raaschou P; Hjemdahl P; Krakau I
Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3180-3189
Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?
Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Rantapaa-Dahlqvist S; Saxne T; Klareskog L
Article: LAKARTIDNINGEN. 2007;104(51-52):3879-3881
[Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects].
Wettermark B; Raaschou P; Forslund T; Hjemdahl P
Article: ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH. 1998;22(6):1185-1189
Modulation of volitional ethanol intake in the rat by central δ-opioid receptors
Franck J; Lindholm S; Raaschou P

Alla övriga publikationer

Editorial: JOURNAL OF MEDICAL ETHICS. 2022;48(3):193
The ethics of disease-modifying drugs targeting Alzheimer disease: response to our commentators
Gustavsson E; Raaschou P; Larfars G; Sandman L; Juth N
Editorial: ANNALS OF INTERNAL MEDICINE. 2018;169(5):I-12
Tumor Necrosis Factor Inhibitors and Cancer Relapse.
Doctoral thesis: 2014
Anti-TNF therapy and malignancy in patients with rheumatoid arthritis : studies on cancer incidence, recurrence and survival
Raaschou P

Anställningar

Anknuten till Undervisning/Handledning, Medicin, Solna, Karolinska Institutet, 2026-2027
Anknuten till Undervisning/Handledning, Neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2014
Läkarexamen, Karolinska Institutet, 1998

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI